Phase I Study of Bevacizumab, Everolimus, and Panobinostat (LBH-589) in Advanced Solid Tumors

Por Strickler, John H., Starodub, Alexander N., Jia, Jingquan, Meadows, Kellen L., Nixon, Andrew B., Dellinger, Andrew, Morse, Michael A., Uronis, Hope E., Marcom, P. Kelly, Zafar, S. Yousuf, Haley, Sherri T., Hurwitz, Herbert I.
Publicado em 2012

First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors

Por Starodub, Alexander N., Ocean, Allyson J., Shah, Manish A., Guarino, Michael J., Picozzi, Jr., Vincent J., Vahdat, Linda T., Thomas, Sajeve S., Govindan, Serengulam V., Maliakal, Pius P., Wegener, William A., Hamburger, Steven A., Sharkey, Robert M., Goldenberg, David M.
Publicado no Clin Cancer Res (2015)

A Phase I Study of Bevacizumab, Everolimus, and Panitumumab in Advanced Solid Tumors

Por Vlahovic, Gordana, Meadows, Kellen L., Uronis, Hope E., Morse, Michael A., Blobe, Gerard C., Riedel, Richard F., Zafar, S. Yousuf, Alvarez-Secord, Angeles, Gockerman, Jon, Starodub, Alexander N., Ready, Neal E., Anderson, Elizabeth L., Bendell, Johanna C., Hurwitz, Herbert I.
Publicado em 2012